Best of the Week
Most Popular
1. The Trump Stock Market Trap May Be Triggered - Barry_M_Ferguson
2.Why are Central Banks Buying Gold and Dumping Dollars? - Richard_Mills
3.US China War - Thucydides Trap and gold - Richard_Mills
4.Gold Price Trend Forcast to End September 2019 - Nadeem_Walayat
5.Money Saving Kids Gardening Growing Giant Sunflowers Summer Fun - Anika_Walayat
6.US Dollar Breakdown Begins, Gold Price to Bolt Higher - Jim_Willie_CB
7.INTEL (INTC) Stock Investing to Profit From AI Machine Learning Boom - Nadeem_Walayat
8.Will Google AI Kill Us? Man vs Machine Intelligence - N_Walayat
9.US Prepares for Currency War with China - Richard_Mills
10.Gold Price Epochal Breakout Will Not Be Negated by a Correction - Clive Maund
Last 7 days
UK House Building and Population Growth Analysis - 17th July 19
Financial Crisis Stocks Bear Market Is Scary Close - 17th July 19
Want to See What's Next for the US Economy? Try This. - 17th July 19
What to do if You Blow the Trading Account - 17th July 19
Bitcoin Is Far Too Risky for Most Investors - 17th July 19
Core Inflation Rises but Fed Is Going to Cut Rates. Will Gold Gain? - 17th July 19
Boost your Trading Results - FREE eBook - 17th July 19
This Needs To Happen Before Silver Really Takes Off - 17th July 19
NASDAQ Should Reach 8031 Before Topping - 17th July 19
US Housing Market Real Terms BUY / SELL Indicator - 16th July 19
Could Trump Really Win the 2020 US Presidential Election? - 16th July 19
Gold Stocks Forming Bullish Consolidation - 16th July 19
Will Fed Easing Turn Out Like 1995 or 2007? - 16th July 19
Red Rock Entertainment Investments: Around the world in a day with Supreme Jets - 16th July 19
Silver Has Already Gone from Weak to Strong Hands - 15th July 19
Top Equity Mutual Funds That Offer Best Returns - 15th July 19
Gold’s Breakout And The US Dollar - 15th July 19
Financial Markets, Iran, U.S. Global Hegemony - 15th July 19
U.S Bond Yields Point to a 40% Rise in SPX - 15th July 19
Corporate Earnings may Surprise the Stock Market – Watch Out! - 15th July 19
Stock Market Interest Rate Cut Prevails - 15th July 19
Dow Stock Market Trend Forecast Current State July 2019 Video - 15th July 19
Why Summer is the Best Time to be in the Entertainment Industry - 15th July 19
Mid-August Is A Critical Turning Point For US Stocks - 14th July 19
Fed’s Recessionary Indicators and Gold - 14th July 19
The Problem with Keynesian Economics - 14th July 19
Stocks Market Investors Worried About the Fed? Don't Be -- Here's Why - 13th July 19
Could Gold Launch Into A Parabolic Upside Rally? - 13th July 19
Stock Market SPX and Dow in BREAKOUT but this is the worrying part - 13th July 19
Key Stage 2 SATS Tests Results Grades and Scores GDS, EXS, WTS Explained - 13th July 19
INTEL Stock Investing in Qubits and AI Neural Network Processors - Video - 12th July 19
Gold Price Selloff Risk High - 12th July 19
State of the US Economy as Laffer Gets Laughable - 12th July 19
Dow Stock Market Trend Forecast Current State - 12th July 19
Stock Market Major Index Top In 3 to 5 Weeks? - 11th July 19
Platinum Price vs Gold Price - 11th July 19
What This Centi-Billionaire Fashion Magnate Can Teach You About Investing - 11th July 19
Stock Market Fundamentals are Weakening: 3000 on SPX Means Nothing - 11th July 19
This Tobacco Stock Is a Big Winner from E-Cigarette Bans - 11th July 19
Investing in Life Extending Pharma Stocks - 11th July 19
How to Pay for It All: An Option the Presidential Candidates Missed - 11th July 19
Mining Stocks Flash Powerful Signal for Gold and Silver Markets - 11th July 19
5 Surefire Ways to Get More Viewers for Your Video Series - 11th July 19

Market Oracle FREE Newsletter

Top AI Stocks Investing to Profit from the Machine Intelligence Mega-trend

Everybody Wins in Health Care Reform Except You!

Politics / Healthcare Sector Dec 03, 2009 - 04:04 PM GMT

By: DailyWealth


Best Financial Markets Analysis Article"Everybody wins."

That's my theme for investing in health care in 2010.

As a biotech and health care investment advisor, I've spent over 100 hours in the past month digging through "ObamaCare"... finding the best and safest ways my readers can put their investment dollars to work in the sector. "Everybody wins" is the final result of my research.

I believe "everybody" – meaning just about every health care business you can think of – will win in the coming years because when you ignore the tiny details, political scare tactics, and other garbage spewing from the health care debate, you only need to know one figure to understand ObamaCare: 47 million new customers.

When the dust clears, as many as 47 million new patients will pour into the already massive U.S. health care industry.

Drugmakers, doctors, hospitals, insurance companies, pharmacies, device manufacturers – every health care business – will profit as our bloated system swells further. No taxes, regulations, forced concessions, or margin pressure will dampen the windfall from 47 million new consumers. And the majority of these new customers won't give a damn how much their care costs. Their neighbors will be paying for it.

So everybody will emerge a victor... with just one exception.

Who's the loser? You, the consumer.

Don't be fooled into thinking Washington and the health care industry are at odds over medical reform.

Conventional thinking says the private sector vehemently resists any government interference in free markets. As such, drugmakers, insurance companies, and other health care players should be fighting to keep legislators out of their business, right? From the surface, that appears to be the case.

This year, health care lobbyists are spending as much as $2 million a day pushing, prodding, and pampering legislators. Each lobbyist is striving to minimize the damage new reform will cause his client, while maximizing the benefit of tens of millions of uninsured joining the system. (Estimates on the exact number vary, but range between 30 million and 47 million.)

Through the third quarter of the year, the health care lobby had already outspent its entire 2008 outlay ($486 million). By the end of the year, the estimated $550 million tally will easily be the costliest advocacy campaign in U.S. history. But this superficial arm-twisting between special interest groups and lawmakers is no battle. It's a mating ritual.

Records show more than 350 former legislative staff and Congress members have crossed the divide as private-sector advocates. At least half of these insiders have direct work experience (including two former chiefs of staff) with Senators Max Baucus (D-Montana) and Chuck Grassley (R-Iowa), respectively the chairman and ranking member of the Senate Finance Committee, the most important group in shaping the health care reform bill.

And it's not only a one-way ticket from Congress to the private sector. Washington's revolving door routinely sucks players from industry into government roles, as well.

Luke Mitchell of Harper's magazine recently identified the driving force behind the Senate Finance Committee's reform agenda. It isn't Senator Baucus. Rather, it's Liz Fowler, Baucus' top aide and director of the committee's health care staff.

Fowler booked four years of political experience working for Baucus from 2001 to 2005. She left Washington for a high-paying job in the health care industry, as vice president of public policy and external affairs at WellPoint – one of the largest U.S. insurance companies. Then, "sensing that a Democratic-controlled Congress would make progress on overhauling the health care system," Fowler returned to Baucus' side in 2008 (as the Beltway gossip paper Politico wrote at the time).

Or consider Nancy-Ann DeParle, the so-called health care "czar" spearheading reform efforts for the White House. DeParle has a similar career path to Fowler's. Her former government jobs include director of what's now known as the Centers for Medicare and Medicaid Services, as well as a stint at the Office of Management and Budget under President Clinton.

But between Democratic presidents, DeParle jumped into the private sector. She served on the boards of several major health care firms, netting more than $6 million as director with medical device makers DaVita, Guidant, and Boston Scientific, health care IT company Cerner, Triad Hospital Systems, and others.

Never mind that during her directorship five of DeParle's companies paid more than $550 million in penalties for fraud, product liability, and antitrust matters – many of which involved tax dollars directly from Medicare and Medicaid.

As you can see, this is a dirty game. The players are making the rules. And everybody – but you – wins.

It will likely become the biggest government boondoggle ever conceived. In tomorrow's essay, I'll continue the story. You'll get more information on why you should be invested in health care right now... including my No. 1 favorite niche. My choice will surprise you.

Good investing,

Rob Fannon

The DailyWealth Investment Philosophy: In a nutshell, my investment philosophy is this: Buy things of extraordinary value at a time when nobody else wants them. Then sell when people are willing to pay any price. You see, at DailyWealth, we believe most investors take way too much risk. Our mission is to show you how to avoid risky investments, and how to avoid what the average investor is doing. I believe that you can make a lot of money – and do it safely – by simply doing the opposite of what is most popular.

Customer Service: 1-888-261-2693 – Copyright 2009 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202

Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.

Daily Wealth Archive

© 2005-2019 - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.

Post Comment

Only logged in users are allowed to post comments. Register/ Log in

6 Critical Money Making Rules